申请人:EISAI R&D MAN CO LTD
                            
                            
                                公开号:WO2017066633A1
                            
                            
                                公开(公告)日:2017-04-20
                            
                            We provide compounds given by Formula I, which is shown in FIG. 3, or pharmaceutically acceptable salts thereof, as well as formulations thereof and methods of use of those compounds and formulations for treatment of cancer.